Startseite › Eierstockkrebs › Minnesota › Minneapolis
Klinische Studien zu Eierstockkrebs in Minneapolis, MN
24 Studien zu Eierstockkrebs suchen Teilnehmer an Standorten in und um Minneapolis (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Teilnehmer gesuchtPhase 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi entfernt
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Teilnehmer gesuchtPhase 2
- University Of Minnesota /ID# 277850, Minneapolis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mi entfernt
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Teilnehmer gesuchtPhase 2
- University of Minnesota - Minneapolis /ID# 275718, Minneapolis
- Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 274780, Saint Louis Park · 5 mi entfernt
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Teilnehmer gesuchtPhase 3
- Masonic Cancer Center, University of Minnesota, Minneapolis
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Teilnehmer gesuchtPhase 2
- Minnesota Oncology-Minneapolis, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- University of Minnesota Masonic Cancer Center, Minneapolis
The Vanguard Study: Testing a New Way to Screen for Cancer
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Minneapolis VA Medical Center, Minneapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- University of Minnesota, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Teilnehmer gesuchtPhase 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Teilnehmer gesuchtPhase 1
- Normunity Investigational Site, Minneapolis
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Teilnehmer gesucht
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- und 2 weitere
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Teilnehmer gesuchtPhase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- und 2 weitere
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Teilnehmer gesuchtPhase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Teilnehmer gesuchtPhase 2
- 518, Minneapolis
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Teilnehmer gesuchtPhase 2
- University of Minnesota - Masonic Cancer Center, Minneapolis
UNTOLD Ovarian Cancer Unmet Needs Survey
Teilnehmer gesuchtBeobachtungsstudie
- Masonic Cancer Center, Minneapolis
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Teilnehmer gesuchtPhase 3
- Minnesota Oncology Hematology PA, Minneapolis
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
Teilnehmer gesuchtGesunde Freiwillige willkommen
- University of Minnesota, Minneapolis
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Teilnehmer gesuchtPhase 1
- University of Minnesota, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Allina Health Cancer Institute, Minneapolis
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Teilnehmer gesuchtPhase 2
- SCRI - Minnesota Oncology Hematology, P.A., Minneapolis
- University of Minnesota, Minneapolis
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
Teilnehmer gesuchtPhase 1
- University of Minnesota, Minneapolis
Eierstockkrebs-Studien in anderen Städten
- Houston, TX89 Studien
- New York City, NY69 Studien
- Boston, MA61 Studien
- Los Angeles, CA50 Studien
- Nashville, TN49 Studien
- Arlington, VA46 Studien
- Philadelphia, PA44 Studien
- Columbus, OH39 Studien
- St. Louis, MO38 Studien
- Chicago, IL36 Studien
- San Antonio, TX31 Studien
- Cleveland, OH30 Studien
Weitere Studien in Minneapolis
- Brustkrebs27 Studien
- Nichtkleinzelliges Lungenkarzinom26 Studien
- Prostatakrebs23 Studien
- Krebs (alle Arten)22 Studien
- Herzinsuffizienz21 Studien
- Lungenkrebs20 Studien
- Akute myeloische Leukämie20 Studien
- Kolorektales Karzinom19 Studien
- Endometriumkarzinom18 Studien
- Parkinson-Krankheit17 Studien
- Herz-Kreislauf-Erkrankungen15 Studien
- Koronare Herzkrankheit13 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.